Navigation Links
NPC Conference to Address Questions on Ability to Share Health Research Findings
Date:2/6/2012

WASHINGTON, Feb. 6, 2012 /PRNewswire-USNewswire/ -- To examine key issues around asymmetries, or inequalities, in communicating health information coming from the growing body of comparative effectiveness research (CER), the National Pharmaceutical Council, the National Health Council and WellPoint are sponsoring a conference, Asymmetry in the Ability to Communicate CER Findings: Ethics and Issues for Informed Decision Making. 

With billions of dollars in funding being invested in comparative effectiveness research, patients, providers, payers and other health care decision-makers will have more information than ever before about the safety and effectiveness of treatment options. However, not all stakeholders have equal ability to share information in the current regulatory environment. The conference will facilitate discussion about the information needs of patients, payers and other stakeholders, and how the First Amendment and other legal issues apply. Presenters will share with attendees a proposed ethical framework for communicating CER information.

Who: Confirmed speakers include:

  • Arthur Caplan, PhD, Director, Center for Bioethics, University of Pennsylvania
  • Susan Dentzer, Editor-in-Chief, Health Affairs/Project HOPE
  • Robert W. Dubois, MD, PhD, Chief Science Officer, National Pharmaceutical Council
  • Scott Gottlieb, MD, Resident Fellow, American Enterprise Institute
  • Stephen Hume, PsyD, Alzheimer's patient representative, and his care partner, Candace Darcy
  • Aaron S. Kesselheim, MD, JD, MPH, Assistant Professor of Medicine, Harvard Medical School
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital
  • Joshua D. Lenchus, DO, RPh, FACP, Associate Director, University of Miami-Jackson Memorial Hospital Center for Patient Safety, and Associate Professor of Medicine, University of Miami Miller School of Medicine
  • Gerald F. Masoudi, Partner, Covington & Burling LLP
  • Steven J. Romano, MD, Senior Vice President, Head, Medicines Development Group, Primary Care Business, Pfizer Inc
  • Robert J. Temple, MD, Deputy Center Director for Clinical Science, U.S. Food and Drug Administration's (FDA's) Center for Drug Evaluation and Research, and Acting Deputy Director of the FDA's Office of Drug Evaluation I
  • Tevi Troy, PhD, Senior Fellow, Hudson Institute, and former Deputy Secretary, U.S. Department of Health and Human Services
  • Marcus Wilson, PharmD, President, HealthCore

When: Thursday, February 9, 2012, from 9:30 a.m. to 4:30 p.m.  The conference will open at 8:30 a.m. for registration and a continental breakfast.

Where:  Omni Shoreham Hotel, 2500 Calvert St. NW, Washington, D.C.  

Registration is complimentary at http://www.npcnow.org/asym12.     

To join the conversation on Twitter, use the hashtag #asym12.


'/>"/>
SOURCE National Pharmaceutical Council
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Webcast Alert: Heska Announces Fourth Quarter and Year-End 2011 Earnings Conference Call Webcast
2. Stryker Presents Results of the TREVO Prospective Clinical Study at the International Stroke Conference
3. American Pacific to Release Financial Results and Hold Fiscal 2012 First Quarter Investor Teleconference
4. CryoLife Announces Release Date and Teleconference Call Details for 2011 Fourth Quarter and Year End Financial Results
5. Winner Medical Group Inc. to Host First Quarter 2012 Earnings Conference Call on Thursday, February 9, 2012 at 08:00 p.m. EST
6. Vision-Sciences, Inc. to Webcast, Live, at RetailInvestorConferences.com on February 2nd
7. ThermoGenesis Provides Update on Res-Q® Clinical Evaluations at Leading Stem Cell Therapy Conference
8. Hill-Rom to Participate in the Leerink Swann 2012 Global Healthcare Conference
9. Auxilium Pharmaceuticals to Present at the Leerink Swann 2012 Global Healthcare Conference
10. Regeneron to Report Full Year 2011 Financial and Operating Results and Host Conference Call and Webcast on February 16, 2012
11. Palomar Medical Technologies to Host Fourth Quarter and Year End 2011 Financial Results Conference Call and Webcast on February 9, 2012 at 11:30 AM Eastern Time
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2016)... , May 5, 2016 ... addition of the  "Europe Thalassaemia Market and ... their offering.       (Logo: ... Europe Thalassaemia Market and Competitive Landscape Highlights ... pipeline products, Thalassaemia epidemiology, Thalassaemia market valuations ...
(Date:5/4/2016)... Holdings (NYSE: CODI ) ("CODI," "we," "our" ... businesses, announced today its consolidated operating results for the ... Quarter 2016 Highlights , Generated Cash Flow Available ... $13.6 million for the first quarter of 2016; ... first quarter of 2016; , Paid a first ...
(Date:5/4/2016)...  It,s time for an upgrade. There are many medical recorders on the market ... the illustrious DVMAXX HD  offers unparalleled connectivity and functionality.  Ampronix  is a renowned ... manufacturer of innovative technology.  Photo - http://photos.prnewswire.com/prnh/20160503/363416 ... ... ...
Breaking Medicine Technology:
(Date:5/5/2016)... ... May 05, 2016 , ... Derrin Doty Group has unveiled the latest ... Orchard and communities west of Seattle. The insurance provider’s caring team has been so ... died suddenly due to complications from the flu, that they have decided to extend ...
(Date:5/5/2016)... ... 05, 2016 , ... Michael Lanteri Agency in Fort Collins, ... the people of their local community. The agency pledges to select a new ... hope is to bring awareness to important local causes with fundraising and other ...
(Date:5/5/2016)... ... May 05, 2016 , ... Long Island’s fastest growing comprehensive eye ... Long Island eye surgeon, Kathleen Van Valkenburg, MD as part of their ongoing effort ... MD, medical director and managing partner of North Shore Eye Care. , “We ...
(Date:5/5/2016)... ... May 05, 2016 , ... A local study examining asthma ... 40 percent of participating fifth-grade students already have or are at risk for ... Research in the Division of Pulmonary, Allergy and Critical Care Medicine at ...
(Date:5/5/2016)... ... , ... Dr. Benjamin Stong of Kalos Facial Plastic Surgery, LLC in Atlanta, ... double board certified and the only facial plastic surgeon in Atlanta to offer ... such as stem cells can be used to provide stabilization to hair transplant results ...
Breaking Medicine News(10 mins):